# Effects of Semaglutide on Nicotine Intake

> **NCT05530577** · PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 24 (actual)

## Conditions studied

- Tobacco Use Disorder
- Nicotine Addiction

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Sham/placebo

## Key facts

- **NCT ID:** NCT05530577
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-07
- **Primary completion:** 2024-05-13
- **Final completion:** 2024-05-13
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05530577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05530577, "Effects of Semaglutide on Nicotine Intake". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05530577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*